FDA: Foreign Inspections postponed due to Coronavirus
The US FDA announced that it is postponing most foreign inspections through April with immediate effect due to the Coronavirus disease. Inspections outside the US that are considered critical will be reviewed by the FDA on a case-by-case basis.
The decision is based on a travel ban for government employees issued by the Center for Disease Control and Prevention. The FDA further states that a supervision of international manufacturers and imported products will be provided by alternative measures.
The resumption of foreign inspections will be resumed as soon as possible.
Source:
FDA: Press Release
Meet the GMP Compliance Adviser
The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business.
The demo access is non-binding and ends automatically.
You may also be interested in the following articles:
